{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:11:16Z","timestamp":1788851476028,"version":"build-2803163510"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council of Taiwan","doi-asserted-by":"crossref","award":["MOST 111-2314-B-303-027-MY2"],"award-info":[{"award-number":["MOST 111-2314-B-303-027-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council of Taiwan","doi-asserted-by":"crossref","award":["NSCT 111-2314-B-005-002-MY3"],"award-info":[{"award-number":["NSCT 111-2314-B-005-002-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council of Taiwan","doi-asserted-by":"crossref","award":["MOST 110-2314-B-303-017-MY3"],"award-info":[{"award-number":["MOST 110-2314-B-303-017-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100022298","name":"Hualien Tzu Chi Hospital","doi-asserted-by":"crossref","award":["IMAR-110-01-20"],"award-info":[{"award-number":["IMAR-110-01-20"]}],"id":[{"id":"10.13039\/501100022298","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Feature Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education","award":["MOE-113-S-0023-A"],"award-info":[{"award-number":["MOE-113-S-0023-A"]}]},{"name":"The joint research program of Taichung Veteran General Hospital and National Chung Hsing University","award":["TCVGH-NCHU 1127604"],"award-info":[{"award-number":["TCVGH-NCHU 1127604"]}]},{"name":"Gwo Xi Stem Cell Applied Technology Co., Ltd.","award":["MF00A130SS12"],"award-info":[{"award-number":["MF00A130SS12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01399-4","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T10:55:15Z","timestamp":1779792915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cryopreservable dopaminergic progenitors derived from human iPSCs with accelerated loss of pluripotency and early functional restoration in Parkinsonian rats"],"prefix":"10.1038","volume":"12","author":[{"given":"Chia-Yu","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Yun","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Chien","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chiang","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hsuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Shuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hsuan","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Cheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Hsiang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Hsuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chung","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horng-Jyh","family":"Harn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Lin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinn-Zong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"1399_CR1","doi-asserted-by":"publisher","unstructured":"Varadi, C. Clinical features of Parkinson\u2019s Disease: the evolution of critical symptoms. Biology 9, https:\/\/doi.org\/10.3390\/biology9050103","DOI":"10.3390\/biology9050103"},{"key":"1399_CR2","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.neuron.2019.03.004","volume":"101","author":"MM McGregor","year":"2019","unstructured":"McGregor, M. M. & Nelson, A. B. Circuit mechanisms of Parkinson\u2019s disease. Neuron 101, 1042\u20131056 (2019).","journal-title":"Neuron"},{"key":"1399_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3389\/fneur.2018.00711","volume":"9","author":"M Muthuraman","year":"2018","unstructured":"Muthuraman, M. et al. Deep brain stimulation and L-DOPA therapy: concepts of action and clinical applications in Parkinson\u2019s disease. Front, Neurol. 9, 711 (2018).","journal-title":"Front, Neurol."},{"key":"1399_CR4","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/mds.26712","volume":"31","author":"J Nonnekes","year":"2016","unstructured":"Nonnekes, J. et al. Unmasking levodopa resistance in Parkinson\u2019s disease. Mov. Disord. 31, 1602\u20131609 (2016).","journal-title":"Mov. Disord."},{"key":"1399_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/aian.AIAN_239_17","volume":"20","author":"S Pandey","year":"2017","unstructured":"Pandey, S. & Srivanitchapoom, P. Levodopa-induced Dyskinesia: clinical features, pathophysiology, and medical management. Ann. Indian Acad. Neurol. 20, 190\u2013198 (2017).","journal-title":"Ann. Indian Acad. Neurol."},{"key":"1399_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.celrep.2012.04.009","volume":"1","author":"A Kirkeby","year":"2012","unstructured":"Kirkeby, A. et al. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 1, 703\u2013714 (2012).","journal-title":"Cell Rep."},{"key":"1399_CR7","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/stem.1152","volume":"30","author":"J Xi","year":"2012","unstructured":"Xi, J. et al. Specification of midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells 30, 1655\u20131663 (2012).","journal-title":"Stem Cells"},{"key":"1399_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30777-8","volume":"13","author":"Z Alekseenko","year":"2022","unstructured":"Alekseenko, Z. et al. Robust derivation of transplantable dopamine neurons from human pluripotent stem cells by timed retinoic acid delivery. Nat. Commun. 13, 3046 (2022).","journal-title":"Nat. Commun."},{"key":"1399_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.stem.2021.01.005","volume":"28","author":"TW Kim","year":"2021","unstructured":"Kim, T. W. et al. Biphasic activation of WNT signaling facilitates the derivation of midbrain dopamine neurons from hESCs for translational use. Cell Stem Cell 28, 343\u2013355 e345 (2021).","journal-title":"Cell Stem Cell"},{"key":"1399_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks, S. et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease. Nature 480, 547\u2013551 (2011).","journal-title":"Nature"},{"key":"1399_CR11","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1634\/stemcells.2005-0393","volume":"24","author":"A Brederlau","year":"2006","unstructured":"Brederlau, A. et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson\u2019s disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 24, 1433\u20131440 (2006).","journal-title":"Stem Cells"},{"key":"1399_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13097","volume":"7","author":"B Samata","year":"2016","unstructured":"Samata, B. et al. Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1. Nat. Commun. 7, 13097 (2016).","journal-title":"Nat. Commun."},{"key":"1399_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","volume":"2","author":"D Doi","year":"2014","unstructured":"Doi, D. et al. Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Rep. 2, 337\u2013350 (2014).","journal-title":"Stem Cell Rep."},{"key":"1399_CR14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","volume":"619","author":"TY Park","year":"2023","unstructured":"Park, T. Y. et al. Co-transplantation of autologous T(reg) cells in a cell therapy for Parkinson\u2019s disease. Nature 619, 606\u2013615 (2023).","journal-title":"Nature"},{"key":"1399_CR15","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1172\/JCI130767","volume":"130","author":"B Song","year":"2020","unstructured":"Song, B. et al. Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson\u2019s disease models. J. Clin. Invest. 130, 904\u2013920 (2020).","journal-title":"J. Clin. Invest."},{"key":"1399_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.stem.2016.09.004","volume":"20","author":"A Kirkeby","year":"2017","unstructured":"Kirkeby, A. et al. Predictive markers guide differentiation to improve graft outcome in clinical translation of hESC-based therapy for Parkinson\u2019s disease. Cell Stem Cell 20, 135\u2013148 (2017).","journal-title":"Cell Stem Cell"},{"key":"1399_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17165-w","volume":"11","author":"D Doi","year":"2020","unstructured":"Doi, D. et al. Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson\u2019s disease. Nat. Commun. 11, 3369 (2020).","journal-title":"Nat. Commun."},{"key":"1399_CR18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3233\/JPD-212934","volume":"12","author":"S Hiramatsu","year":"2022","unstructured":"Hiramatsu, S. et al. Cryopreservation of induced pluripotent stem cell-derived dopaminergic neurospheres for clinical application. J. Parkinson's Dis. 12, 871\u2013884 (2022).","journal-title":"J. Parkinson's Dis."},{"key":"1399_CR19","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature23664","volume":"548","author":"T Kikuchi","year":"2017","unstructured":"Kikuchi, T. et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model. Nature 548, 592\u2013596 (2017).","journal-title":"Nature"},{"key":"1399_CR20","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.stem.2023.08.014","volume":"30","author":"A Kirkeby","year":"2023","unstructured":"Kirkeby, A. et al. Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson\u2019s disease, STEM-PD. Cell Stem Cell 30, 1299\u20131314 e1299 (2023).","journal-title":"Cell Stem Cell"},{"key":"1399_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","volume":"28","author":"J Piao","year":"2021","unstructured":"Piao, J. et al. Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01. Cell Stem Cell 28, 217\u2013229.e217 (2021).","journal-title":"Cell Stem Cell"},{"key":"1399_CR22","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41591-021-01257-1","volume":"27","author":"Y Tao","year":"2021","unstructured":"Tao, Y. et al. Autologous transplant therapy alleviates motor and depressive behaviors in Parkinsonian monkeys. Nat. Med 27, 632\u2013639 (2021).","journal-title":"Nat. Med"},{"key":"1399_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00926-5","volume":"8","author":"A Morizane","year":"2017","unstructured":"Morizane, A. et al. MHC matching improves engraftment of iPSC-derived neurons in non-human primates. Nat. Commun. 8, 385 (2017).","journal-title":"Nat. Commun."},{"key":"1399_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.stem.2023.11.009","volume":"31","author":"S Park","year":"2024","unstructured":"Park, S. et al. Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson\u2019s disease. Cell Stem Cell 31, 25\u201338.e28 (2024).","journal-title":"Cell Stem Cell"},{"key":"1399_CR25","doi-asserted-by":"publisher","unstructured":"Sawamoto, N. et al. Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease. Nature. https:\/\/doi.org\/10.1038\/s41586-025-08700-0.","DOI":"10.1038\/s41586-025-08700-0"},{"key":"1399_CR26","doi-asserted-by":"publisher","unstructured":"Tabar, V. et al. Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease. Nature. https:\/\/doi.org\/10.1038\/s41586-025-08845-y.","DOI":"10.1038\/s41586-025-08845-y"},{"key":"1399_CR27","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","volume":"382","author":"JS Schweitzer","year":"2020","unstructured":"Schweitzer, J. S. et al. Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson\u2019s Disease. N. Engl. J. Med. 382, 1926\u20131932 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1399_CR28","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1016\/j.cell.2025.09.010","volume":"188","author":"JW Chang","year":"2025","unstructured":"Chang, J. W. et al. Phase 1\/2a clinical trial of hESC-derived dopamine progenitors in Parkinson\u2019s disease. Cell 188, 7036\u20137048.e7011 (2025).","journal-title":"Cell"},{"key":"1399_CR29","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1074\/mcp.RA118.000809","volume":"17","author":"A Fathi","year":"2018","unstructured":"Fathi, A. et al. Discovery of novel cell surface markers for purification of embryonic dopamine progenitors for transplantation in Parkinson\u2019s disease animal models. Mol. Cell Proteom. 17, 1670\u20131684 (2018).","journal-title":"Mol. Cell Proteom."},{"key":"1399_CR30","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.stemcr.2017.08.002","volume":"9","author":"JC Niclis","year":"2017","unstructured":"Niclis, J. C. et al. A PITX3-EGFP reporter line reveals connectivity of dopamine and non-dopamine neuronal subtypes in grafts generated from human embryonic stem cells. Stem Cell Rep. 9, 868\u2013882 (2017).","journal-title":"Stem Cell Rep."},{"key":"1399_CR31","doi-asserted-by":"publisher","first-page":"937","DOI":"10.5966\/sctm.2016-0073","volume":"6","author":"JC Niclis","year":"2017","unstructured":"Niclis, J. C. et al. Efficiently specified ventral midbrain dopamine neurons from human pluripotent stem cells under Xeno-free conditions restore motor deficits in Parkinsonian Rrodents. Stem Cells Transl. Med 6, 937\u2013948 (2017).","journal-title":"Stem Cells Transl. Med"},{"key":"1399_CR32","doi-asserted-by":"publisher","unstructured":"Xu, P. et al. Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson\u2019s disease model. J. Clin. Invest. 132, https:\/\/doi.org\/10.1172\/JCI156768.","DOI":"10.1172\/JCI156768"},{"key":"1399_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/ten.tea.2019.0094","volume":"26","author":"NL Francis","year":"2020","unstructured":"Francis, N. L. et al. Peptide-based scaffolds for the culture and transplantation of human dopaminergic neurons. Tissue Eng. A 26, 193\u2013205 (2020).","journal-title":"Tissue Eng. A"},{"key":"1399_CR34","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.bbagen.2015.04.011","volume":"1850","author":"M Komatsu","year":"2015","unstructured":"Komatsu, M., Konagaya, S., Egawa, E. Y. & Iwata, H. Maturation of human iPS cell-derived dopamine neuron precursors in alginate-Ca(2+) hydrogel. Biochim Biophys. Acta 1850, 1669\u20131675 (2015).","journal-title":"Biochim Biophys. Acta"},{"key":"1399_CR35","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.stemcr.2017.03.010","volume":"8","author":"AS Monzel","year":"2017","unstructured":"Monzel, A. S. et al. Derivation of human midbrain-specific organoids from neuroepithelial stem cells. Stem Cell Rep. 8, 1144\u20131154 (2017).","journal-title":"Stem Cell Rep."},{"key":"1399_CR36","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/stem.3163","volume":"38","author":"TH Kwak","year":"2020","unstructured":"Kwak, T. H. et al. Generation of homogeneous midbrain organoids with in vivo-like cellular composition facilitates neurotoxin-based Parkinson\u2019s disease modeling. Stem Cells 38, 727\u2013740 (2020).","journal-title":"Stem Cells"},{"key":"1399_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.stemcr.2022.10.016","volume":"18","author":"K Nishimura","year":"2023","unstructured":"Nishimura, K. et al. Single-cell transcriptomics reveals correct developmental dynamics and high-quality midbrain cell types by improved hESC differentiation. Stem Cell Rep. 18, 337\u2013353 (2023).","journal-title":"Stem Cell Rep."},{"key":"1399_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05633-1","volume":"7","author":"S Fedele","year":"2017","unstructured":"Fedele, S. et al. Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential. Sci. Rep. 7, 6036 (2017).","journal-title":"Sci. Rep."},{"key":"1399_CR39","doi-asserted-by":"publisher","first-page":"908","DOI":"10.4103\/1673-5374.378203","volume":"19","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons. Neural Regen. Res 19, 908\u2013914 (2024).","journal-title":"Neural Regen. Res"},{"key":"1399_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.stem.2020.08.014","volume":"28","author":"M Xiong","year":"2021","unstructured":"Xiong, M. et al. Human stem cell-derived neurons repair circuits and restore neural function. Cell Stem Cell 28, 112\u2013126.e116 (2021).","journal-title":"Cell Stem Cell"},{"key":"1399_CR41","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1038\/nprot.2017.078","volume":"12","author":"S Nolbrant","year":"2017","unstructured":"Nolbrant, S., Heuer, A., Parmar, M. & Kirkeby, A. Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation. Nat. Protoc. 12, 1962\u20131979 (2017).","journal-title":"Nat. Protoc."},{"key":"1399_CR42","doi-asserted-by":"publisher","first-page":"100065","DOI":"10.1016\/j.xpro.2020.100065","volume":"1","author":"CW Gantner","year":"2020","unstructured":"Gantner, C. W., Cota-Coronado, A., Thompson, L. H. & Parish, C. L. An optimized protocol for the generation of midbrain dopamine neurons under defined conditions. STAR Protoc. 1, 100065 (2020).","journal-title":"STAR Protoc."},{"key":"1399_CR43","doi-asserted-by":"publisher","first-page":"100463","DOI":"10.1016\/j.xpro.2021.100463","volume":"2","author":"L Sarrafha","year":"2021","unstructured":"Sarrafha, L. et al. High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cells. STAR Protoc. 2, 100463 (2021).","journal-title":"STAR Protoc."},{"key":"1399_CR44","doi-asserted-by":"publisher","first-page":"114694","DOI":"10.1016\/j.expneurol.2024.114694","volume":"374","author":"EW Daadi","year":"2024","unstructured":"Daadi, E. W. et al. Combining physical & cognitive training with iPSC-derived dopaminergic neuron transplantation promotes graft integration & better functional outcome in Parkinsonian marmosets. Exp. Neurol. 374, 114694 (2024).","journal-title":"Exp. Neurol."},{"key":"1399_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1161\/STROKEAHA.109.563015","volume":"41","author":"C Seminatore","year":"2010","unstructured":"Seminatore, C. et al. The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke 41, 153\u2013159 (2010).","journal-title":"Stroke"},{"key":"1399_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.brainres.2019.05.040","volume":"1719","author":"SJ Yu","year":"2019","unstructured":"Yu, S. J. et al. NanoCsA improves the survival of human iPSC transplant in hemiparkinsonian rats. Brain Res 1719, 124\u2013132 (2019).","journal-title":"Brain Res"},{"key":"1399_CR47","doi-asserted-by":"publisher","unstructured":"Ting, H. C. et al. Robust generation of ready-to-use cryopreserved motor neurons from human pluripotent stem cells for disease modeling. Int. J. Mol. Sci. 23, https:\/\/doi.org\/10.3390\/ijms232113462.","DOI":"10.3390\/ijms232113462"},{"key":"1399_CR48","doi-asserted-by":"publisher","unstructured":"Ting, H. C. et al. Coactivation of GSK3beta and IGF-1 attenuates amyotrophic lateral sclerosis nerve fiber cytopathies in SOD1 mutant patient-derived motor neurons. Cells 10, https:\/\/doi.org\/10.3390\/cells10102773 (2021).","DOI":"10.3390\/cells10102773"},{"key":"1399_CR49","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3727\/096368913X675179","volume":"24","author":"SM Chen","year":"2015","unstructured":"Chen, S. M. et al. Prerequisite OCT4 maintenance potentiates the neural induction of differentiating human embryonic stem cells and induced pluripotent stem cells. Cell Transplant. 24, 829\u2013844 (2015).","journal-title":"Cell Transplant."},{"key":"1399_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41420-025-02302-5","volume":"11","author":"HC Ting","year":"2025","unstructured":"Ting, H. C. et al. Rapid iPSC-derived neuromuscular junction model uncovers motor neuron dominance in amyotrophic lateral sclerosis cytopathy. Cell Death Discov. 11, 23 (2025).","journal-title":"Cell Death Discov."},{"key":"1399_CR51","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.phrs.2018.10.015","volume":"139","author":"MH Huang","year":"2019","unstructured":"Huang, M. H. et al. Epigenetic targeting DNMT1 of pancreatic ductal adenocarcinoma using interstitial control release biodegrading polymer reduced tumor growth through hedgehog pathway inhibition. Pharm. Res 139, 50\u201361 (2019).","journal-title":"Pharm. Res"},{"key":"1399_CR52","doi-asserted-by":"publisher","unstructured":"Chen, P. Y. et al. Butylidenephthalide Abrogates the Snail-Induced Cancer Stemness in Oral Carcinomas. Int. J. Mol. Sci. 23, https:\/\/doi.org\/10.3390\/ijms23116157.","DOI":"10.3390\/ijms23116157"},{"key":"1399_CR53","doi-asserted-by":"publisher","first-page":"e44024","DOI":"10.1371\/journal.pone.0044024","volume":"7","author":"SP Liu","year":"2012","unstructured":"Liu, S. P. et al. n-Butylidenephthalide (BP) maintains stem cell pluripotency by activating Jak2\/Stat3 pathway and increases the efficiency of iPS cells generation. PLoS One 7, e44024 (2012).","journal-title":"PLoS One"},{"key":"1399_CR54","doi-asserted-by":"publisher","unstructured":"Chuang, H. M. et al. Non-canonical regulation of Type I collagen through promoter binding of SOX2 and its contribution to ameliorating pulmonary fibrosis by Butylidenephthalide. Int. J. Mol. Sci. 19, https:\/\/doi.org\/10.3390\/ijms19103024.","DOI":"10.3390\/ijms19103024"},{"key":"1399_CR55","doi-asserted-by":"publisher","unstructured":"Yen, S. Y. et al. n-Butylidenephthalide regulated tumor stem cell genes EZH2\/AXL and Reduced its migration and invasion in Glioblastoma. Int. J. Mol. Sci. 18, https:\/\/doi.org\/10.3390\/ijms18020372 (2017).","DOI":"10.3390\/ijms18020372"},{"key":"1399_CR56","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stem.2016.03.012","volume":"18","author":"TJ Nowakowski","year":"2016","unstructured":"Nowakowski, T. J. et al. Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells. Cell Stem Cell 18, 591\u2013596 (2016).","journal-title":"Cell Stem Cell"},{"key":"1399_CR57","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.stem.2016.11.011","volume":"19","author":"MF Wells","year":"2016","unstructured":"Wells, M. F. et al. Genetic ablation of AXL does not protect human neural progenitor cells and cerebral organoids from Zika virus infection. Cell Stem Cell 19, 703\u2013708 (2016).","journal-title":"Cell Stem Cell"},{"key":"1399_CR58","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/hmg\/ddt571","volume":"23","author":"MY Son","year":"2014","unstructured":"Son, M. Y., Seol, B., Han, Y. M. & Cho, Y. S. Comparative receptor tyrosine kinase profiling identifies a novel role for AXL in human stem cell pluripotency. Hum. Mol. Genet. 23, 1802\u20131816 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"1399_CR59","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/0963689718757408","volume":"27","author":"K Chi","year":"2018","unstructured":"Chi, K. et al. Adipose-derived stem cells stimulated with n-Butylidenephthalide exhibit therapeutic effects in a mouse model of Parkinson\u2019s disease. Cell Transplant. 27, 456\u2013470 (2018).","journal-title":"Cell Transplant."},{"key":"1399_CR60","doi-asserted-by":"publisher","first-page":"e85305","DOI":"10.1371\/journal.pone.0085305","volume":"9","author":"RH Fu","year":"2014","unstructured":"Fu, R. H. et al. n-butylidenephthalide protects against dopaminergic neuron degeneration and alpha-synuclein accumulation in Caenorhabditis elegans models of Parkinson\u2019s disease. PLoS One 9, e85305 (2014).","journal-title":"PLoS One"},{"key":"1399_CR61","doi-asserted-by":"publisher","unstructured":"Yang, H. H. et al. Anti-Excitotoxic effects of N-Butylidenephthalide revealed by chemically insulted Purkinje progenitor cells derived from SCA3 iPSCs. Int. J. Mol. Sci. 23, https:\/\/doi.org\/10.3390\/ijms23031391.","DOI":"10.3390\/ijms23031391"},{"key":"1399_CR62","doi-asserted-by":"publisher","unstructured":"Wuli, W. et al. Targeting PSEN1 by lnc-CYP3A43-2\/miR-29b-2-5p to reduce beta amyloid plaque formation and improve cognition function. Int. J. Mol. Sci. 23, https:\/\/doi.org\/10.3390\/ijms231810554.","DOI":"10.3390\/ijms231810554"},{"key":"1399_CR63","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.neuropharm.2017.02.014","volume":"117","author":"K Rajamani","year":"2017","unstructured":"Rajamani, K. et al. n-Butylidenephthalide exhibits protection against neurotoxicity through regulation of tryptophan 2, 3 dioxygenase in spinocerebellar ataxia type 3. Neuropharmacology 117, 434\u2013446 (2017).","journal-title":"Neuropharmacology"},{"key":"1399_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/srep08744","volume":"5","author":"CY Chang","year":"2015","unstructured":"Chang, C. Y. et al. N-butylidenephthalide attenuates Alzheimer\u2019s disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons. Sci. Rep. 5, 8744 (2015).","journal-title":"Sci. Rep."},{"key":"1399_CR65","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/cns.12681","volume":"23","author":"QM Zhou","year":"2017","unstructured":"Zhou, Q. M., Zhang, J. J., Li, S., Chen, S. & Le, W. D. n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. CNS Neurosci. Ther. 23, 375\u2013385 (2017).","journal-title":"CNS Neurosci. Ther."},{"key":"1399_CR66","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuropharm.2016.03.035","volume":"108","author":"KW Hsueh","year":"2016","unstructured":"Hsueh, K. W. et al. Autophagic down-regulation in motor neurons remarkably prolongs the survival of ALS mice. Neuropharmacology 108, 152\u2013160 (2016).","journal-title":"Neuropharmacology"},{"key":"1399_CR67","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.celrep.2014.10.008","volume":"9","author":"JF Poulin","year":"2014","unstructured":"Poulin, J. F. et al. Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling. Cell Rep. 9, 930\u2013943 (2014).","journal-title":"Cell Rep."},{"key":"1399_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fnana.2011.00041","volume":"5","author":"MK Lobo","year":"2011","unstructured":"Lobo, M. K. & Nestler, E. J. The striatal balancing act in drug addiction: distinct roles of direct and indirect pathway medium spiny neurons. Front. Neuroanat. 5, 41 (2011).","journal-title":"Front. Neuroanat."},{"key":"1399_CR69","doi-asserted-by":"publisher","first-page":"1327423","DOI":"10.3389\/fnins.2024.1327423","volume":"18","author":"S Miao","year":"2024","unstructured":"Miao, S. et al. Tyro3 promotes the maturation of glutamatergic synapses. Front. Neurosci. 18, 1327423 (2024).","journal-title":"Front. Neurosci."},{"key":"1399_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-97557-4","volume":"15","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. Genetically engineered BMSCs promote dopamine secretion and ameliorate motor dysfunction in a Parkinson\u2019s disease rat model. Sci. Rep. 15, 12514 (2025).","journal-title":"Sci. Rep."},{"key":"1399_CR71","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3892\/etm.2017.4054","volume":"13","author":"M Gao","year":"2017","unstructured":"Gao, M. et al. Syringe needle skull penetration reduces brain injuries and secondary inflammation following intracerebral neural stem cell transplantation. Exp. Ther. Med. 13, 885\u2013890 (2017).","journal-title":"Exp. Ther. Med."},{"key":"1399_CR72","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/cns.13378","volume":"26","author":"B Bonsack","year":"2020","unstructured":"Bonsack, B. et al. Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury. CNS Neurosci. Ther. 26, 603\u2013615 (2020).","journal-title":"CNS Neurosci. Ther."},{"key":"1399_CR73","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","volume":"27","author":"SM Chambers","year":"2009","unstructured":"Chambers, S. M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275\u2013280 (2009).","journal-title":"Nat. Biotechnol."},{"key":"1399_CR74","doi-asserted-by":"publisher","first-page":"963689721101782","DOI":"10.1177\/09636897211017829","volume":"30","author":"CY Chang","year":"2021","unstructured":"Chang, C. Y. et al. Differentiation of human pluripotent stem cells into specific neural lineages. Cell Transplant. 30, 9636897211017829 (2021).","journal-title":"Cell Transplant."},{"key":"1399_CR75","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.stemcr.2017.04.033","volume":"9","author":"DR Wakeman","year":"2017","unstructured":"Wakeman, D. R. et al. Cryopreservation maintains functionality of human iPSC Dopamine neurons and rescues Parkinsonian phenotypes in vivo. Stem Cell Rep. 9, 149\u2013161 (2017).","journal-title":"Stem Cell Rep."},{"key":"1399_CR76","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3727\/096368909788341324","volume":"18","author":"G Nikkhah","year":"2009","unstructured":"Nikkhah, G. et al. Microtransplantation of dopaminergic cell suspensions: further characterization and optimization of grafting parameters. Cell Transpl. 18, 119\u2013133 (2009).","journal-title":"Cell Transpl."},{"key":"1399_CR77","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1038\/s41380-022-01628-1","volume":"27","author":"H Li","year":"2022","unstructured":"Li, H. et al. Generation of human A9 dopaminergic pacemakers from induced pluripotent stem cells. Mol. Psychiatry 27, 4407\u20134418 (2022).","journal-title":"Mol. Psychiatry"},{"key":"1399_CR78","doi-asserted-by":"publisher","first-page":"e70014","DOI":"10.1002\/btm2.70014","volume":"10","author":"X Zheng","year":"2025","unstructured":"Zheng, X., Chen, J., Huang, Z., Zhang, Y. & Zhou, L. Efficacy and safety assessment of homotopical transplantation of iPSCs-derived midbrain organoids into the substantia nigra of Parkinsonian rats. Bioeng. Transl. Med. 10, e70014 (2025).","journal-title":"Bioeng. Transl. Med."},{"key":"1399_CR79","first-page":"1052","volume":"29","author":"M Deleidi","year":"2011","unstructured":"Deleidi, M., Hargus, G., Hallett, P., Osborn, T. & Isacson, O. Development of histocompatible primate-induced pluripotent. Stem Cells Neural Transplant. Stem Cells 29, 1052\u20131063 (2011).","journal-title":"Stem Cells Neural Transplant. Stem Cells"},{"key":"1399_CR80","doi-asserted-by":"publisher","first-page":"15921","DOI":"10.1073\/pnas.1010209107","volume":"107","author":"G Hargus","year":"2010","unstructured":"Hargus, G. et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl. Acad. Sci. USA 107, 15921\u201315926 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1399_CR81","doi-asserted-by":"publisher","first-page":"564612","DOI":"10.1155\/2012\/564612","volume":"2012","author":"CC Macarthur","year":"2012","unstructured":"Macarthur, C. C. et al. Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int. 2012, 564612 (2012).","journal-title":"Stem Cells Int."},{"key":"1399_CR82","doi-asserted-by":"publisher","first-page":"963689723119817","DOI":"10.1177\/09636897231198172","volume":"32","author":"CY Lin","year":"2023","unstructured":"Lin, C. Y. et al. Coating-free culture medium for establishing and maintaining human induced pluripotent stem cells. Cell Transplant. 32, 9636897231198172 (2023).","journal-title":"Cell Transplant."}],"updated-by":[{"DOI":"10.1038\/s41531-026-01569-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000}}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01399-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01399-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01399-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:03:29Z","timestamp":1788851009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01399-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1399"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01399-4","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41531-026-01569-4","URL":"https:\/\/doi.org\/10.1038\/s41531-026-01569-4","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. H.-L.S. is the founder and president of DuoGenic StemCells Corporation in Taiwan, which constitutes a financial competing interest. This study was not conducted in collaboration with the company and did not receive any funding from it. Dr. C.-Y.C. is an inventor on a pending patent related to one aspect of this study (applicant: Buddhist Tzu Chi Medical Foundation; application number: 18\/971,399; status: pending), which constitutes a financial competing interest. The other authors do not have a competing interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"158"}}